1. Abnormalities in lipoprotein metabolism in hemodialysis patients
Michaela Königer, M.D., Thomas Quaschning, Christoph Wanner, Peter Schollmeyer, Annette Krämer-Guth 
Kidney International 
Volume 56, Pages S248-S250 (July 1999)
DOI: /j x
Copyright © 1999 International Society of Nephrology Terms and Conditions

2. Figure 1
Concentration-dependent degradation of 125I-labeled low-density lipoprotein (LDL) by cultures of HepG2 cells. LDL obtained from healthy controls (open bars), LDL obtained from hemodialysis patients (serum triglycerides > 2.28 mmol/liter, dotted bars), and LDL obtained from hemodialysis patients with non–insulin-dependent diabetes mellitus (serum triglycerides > 2.28 mmol/liter, hatched bars). Data are given as mean ±SEM of 10 subjects in every group. All measurements were carried out in triplicate. *P < 0.05 vs. controls.
Kidney International  , S248-S250DOI: ( /j x)
Copyright © 1999 International Society of Nephrology Terms and Conditions